Backing 29 domestic firms along with KOTRA
[by Yu, Suin] The Korea Biotechnology Industry Organization (KoreaBIO) announced on June 10 that it has organized a large-scale Korean pavilion at the 'BIO International Convention 2025 (BIO USA),' the world's largest biotechnology industry exhibition, scheduled to take place in Boston, USA, from June 16 to 19 for four days (local time). The KoreaBIO and KOTRA will jointly operate the 'Korea Pavilion,' covering an area of 6,000 square feet, to support the global expansion of 29 Korean companies and organizations.
The 바카라 에볼루션 Pavilion, operated for the 22nd consecutive year, has reached its largest scale yet in terms of both the number of participating companies and the exhibition area, surpassing last year’s figures. It plans to bolster global partnering results for 바카라 에볼루션n companies by strengthening customized partnering initiatives and on-site promotional activities.
The 바카라 에볼루션 Pavilion exhibition will showcase companies representing the full spectrum of the biotechnology industry, including contract manufacturing (CMO) and clinical services, small and medium-sized businesses (materials, parts, and equipment), novel drug development, and platform technologies. In total, 51 companies will participate, comprising 26 companies chosen by the KoreBIO and KOTRA through a government-supported selection process and 25 companies selected by three organizations: Seoul Biohub, Chuncheon Bioindustry Foundation, and the 바카라 에볼루션 Planning & Evaluation Institute of Industrial Technology (KEIT).
Notably, the partnering consultation center, which had previously operated in an open format, was partially closed to better meet the specific needs of participating companies. In addition to the exhibition promotion booth, an IR pitching stage will be set up to maximize the promotional impact of participating companies, while support for international network expansion and investment meetings will be maximized.
In addition to managing the 바카라 에볼루션n Pavilion, 바카라 에볼루션BIO will also participate as a representative of 바카라 에볼루션 in the official meetings and conference panels at this year’s BIO USA event. On June 15 (local time), the 바카라 에볼루션BIO plans to attend the closed-door general meeting of the 'International Council of Biotechnology Associations (ICBA),' where biotech association officials from around the world discuss the status of the biotechnology industry in each country and identify cooperative opportunities. At the council, 바카라 에볼루션BIO aims to share major issues related to the 바카라 에볼루션n biotechnology industry and highlight the importance of international cooperation. Key topics will include the domestic impact of the new U.S. government's bio-industry policies, cooperation tasks for stabilizing the global biopharmaceutical supply chain, and the current status of 바카라 에볼루션’s biotech industry.
Then, on June 18, during the main event afternoon conference session titled 'Building Resilient Global and National Supply Chains,' Hwang Ju-ri, Head of Exchange and Cooperation Headquarters at the 바카라 에볼루션BIO, will participate as a representative panelist for 바카라 에볼루션. She will discuss strategies and international cooperation efforts aimed at securing stable supply chains in each country that have become increasingly vulnerable due to recent geopolitical tensions and climate change.
The 바카라 에볼루션BIO will also organize a side event representing 바카라 에볼루션. The event, '바카라 에볼루션 BioTech Partnership (KBTP) @ BIO 2025,' will take place from 6 p.m. on June 17, the second day of the convention. It will be co-hosted by the 바카라 에볼루션BIO, KOTRA, the 바카라 에볼루션 Planning & Evaluation Institute of Industrial Technology (KEIT), the 바카라 에볼루션 Exchange, Invest Seoul, and Gyeonggido Business & Science Accelerator (GBSA). The event will serve as a networking event that provides the opportunity to foster cooperation with international investors and companies.
The KBTP event is structured into two parts: Part 1 (바카라 에볼루션 Capital Market Spotlight) and Part 2 (Meet the 바카라 에볼루션n Biotechs). In Part 1, speakers will present 바카라 에볼루션’s strategies for attracting international companies, guidelines for listing on KOSDAQ, and procedures for entering the 바카라 에볼루션n market to overseas biotech firms and investors. The session will feature speakers from Invest Seoul, the 바카라 에볼루션 Exchange, 바카라 에볼루션 Investment Partners, Samsung Securities, Bae, Kim & Lee Law Firm, and Samil PwC Accountings, who will share practical entry strategies and insights into 바카라 에볼루션’s investment and listing environment.
During the networking session of Part 2, ABL Bio, which has signed technology transfer agreements with global pharmaceutical companies like Sanofi and GlaxoSmithKline (GSK), will deliver the first presentation. Following this, Yuhan Corporation, which secured a technology transfer deal worth around KRW 1.6 trillion (approximately USD 1.1 billion) with a Johnson & Johnson (J&J) subsidiary and has received novel drug approval from the U.S. Food and Drug Administration (FDA), will participate as a speaker to share its know-how on global cooperation. The presentation will highlight strategies for 바카라 에볼루션n biotech companies entering the global market and key partnership examples. In particular, the Head of Asia Partnering at Roche, a multinational pharmaceutical company, will also speak, discussing cases of collaboration with Asian and 바카라 에볼루션n biotech companies and emphasizing the global potential and competitiveness of 바카라 에볼루션’s bio industry.
This year’s KBTP event will bring together not only promising biotech companies but also government officials, representatives from global pharmaceutical companies, venture capitalists (VCs), and other key players who shape the global bio ecosystem, fostering extensive networking opportunities. Pre-registration for the event is available through the 바카라 에볼루션BIO’s official website.
“This year, through BIO USA, we will fully support domestic biotech companies by mobilizing every available resource to promote their technologies and facilitate collaboration and exchange with international markets,” stated Hwang Ju-ri, Head of Exchange and Cooperation Headquarters at the 바카라 에볼루션BIO. “We will definitely demonstrate the competitive strength of the 바카라 에볼루션n bio industry in the global arena,” she added.